首页> 外文OA文献 >ABL-specific tyrosine kinase inhibitor, STI571 in vitro, affects Ph-positive acute lymphoblastic leukemia and chronic myelogenous leukemia in blastic crisis

【2h】

ABL-specific tyrosine kinase inhibitor, STI571 in vitro, affects Ph-positive acute lymphoblastic leukemia and chronic myelogenous leukemia in blastic crisis

机译：Abl-特异性酪氨酸激酶抑制剂STI571在体外影响PH阳性急性淋巴细胞白血病和慢性骨髓性白血病在弹力危机中

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
A Nakajima; T Tauchi; K Ohyashiki;
展开▼
作者单位

展开▼
年度 2001
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Efficacy and Safety of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in Chronic Myeloid Leukemia Activity of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in the Blast Crisis of Chronic Myeloid Leukemia and Acute Lympoblastic Leukemia wit [J] . B. J. Druker, M. Talpaz, D. J. Resta, Chemtracts . 2001,第13期

机译：BCR-ABL酪氨酸激酶特异性抑制剂在慢性粒细胞白血病中的功效和安全性BCR-ABL酪氨酸激酶特异性抑制剂在慢性粒细胞白血病和急性淋巴细胞白血病机智的爆发危机中的活性
2. Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome. [J] . Druker BJ, Sawyers CL, Kantarjian H, The New England journal of medicine . 2001,第14期

机译：BCR-ABL酪氨酸激酶的特异性抑制剂在费城染色体的慢性粒细胞白血病和急性淋巴细胞白血病的原始危机中的活性。
3. Prior treatment with the tyrosine kinase inhibitors dasatinib and nilotinib allows stem cell transplantation (SCT) in a less advanced disease phase and does not increase SCT Toxicity in patients with chronic myelogenous leukemia and philadelphia positive acute lymphoblastic leukemia [J] . A Shimoni, M Leiba, M Schleuning, Leukemia . 2009,第1期

机译：事先使用酪氨酸激酶抑制剂达沙替尼和尼洛替尼进行治疗可使干细胞移植（SCT）处于较不晚期的疾病阶段，并且不会增加慢性骨髓性白血病和费城阳性的急性淋巴细胞白血病患者的SCT毒性
4. Novel Inhibitors of T315I Mutant BCR-ABL1 Tyrosine Kinase for Chronic Myeloid Leukemia Disease Through Fragment-Based Drug Design [C] . Satya Anindita, Atika Marnolia, Hersal Hermana Putra, International symposium on bioinformatics research and applications . 2018

机译：T315I突变BCR-ABL1酪氨酸激酶的新型抑制剂通过基于片段的药物设计治疗慢性粒细胞白血病
5. Volatile Biomarkers from Cultured Human Immune Cells, Cultured Human Acute Lymphoblastic Leukemia Cells and the Exhaled Breath of Patients with Acute Myelogenous Leukemia [D] . Umber, Brandon James 2012

机译：培养的人类免疫细胞，培养的人类急性淋巴细胞白血病细胞和急性粒细胞性白血病患者呼气中的挥发性生物标志物
6. Myelomastocytic Blast Cell Crisis in Resistant Tyrosine Kinase Inhibitor Chronic Myelogenous Leukemia: Case Report and Review of Literature [O] . Humberto Martinez-Cordero, Bonell Patiño-Escobar, Leonardo J Enciso, -1

机译：抗酪氨酸激酶抑制剂慢性粒细胞性白血病的骨髓细胞爆炸细胞危机：病例报告和文献复习。
7. Multiple BCR-ABL kinase domain mutations confer polyclonal resistance to the tyrosine kinase inhibitor imatinib (STI571) in chronic phase and blast crisis chronic myeloid leukemia [O] . Shah Neil P., Nicoll John M., Nagar Bhushan, 2002

机译：多个BCR-ABL激酶结构域突变在慢性期和胚芽危机性慢性粒细胞白血病中赋予酪氨酸激酶抑制剂伊马替尼（STI571）多克隆耐药性

ABL-specific tyrosine kinase inhibitor, STI571 in vitro, affects Ph-positive acute lymphoblastic leukemia and chronic myelogenous leukemia in blastic crisis

著录项

相似文献

相关主题

期刊订阅